secwatch.observer — SEC 8-K summary
======================================

Issuer:     Drugs Made In America Acquisition II Corp. (DMII)
CIK:        0002040475
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001213900-26-024387
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

DMIIU CEO Lynn Stockwell resigns after Sponsor fails to repay $566K overpayment; Roger Bendelac appointed CEO
--------------------------------------------------------------------------------

- Lynn Stockwell resigned as CEO, Executive Chair, and Board member on Feb 28, 2026, after Board learned Sponsor could not repay $566,269 overpayment.
- Board accepted resignation and removed Stockwell from all positions effective Feb 28, 2026.
- Roger Bendelac, 69, with 30+ years in investment banking and advisory, appointed CEO effective Feb 28, 2026.
- Sponsor withdrew $1.1M from working capital; $566K+ used for expenses unrelated to the Company and not repaid.
- Bendelac's compensation not yet determined; Board will consider and disclose terms later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/0001213900-26-024387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/ea0280265-8k_drugs2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-024387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer